WellBeam has successfully secured $10 million in Series A financing to enhance its healthcare technology solutions, emphasizing interoperability and electronic medical record integration.

Target Company Overview

WellBeam is a healthcare technology firm focused on enhancing clinical care management by fostering seamless interoperability and integrating electronic medical records (EMR) between acute and post-acute care providers. With the aim of bridging gaps in healthcare delivery, WellBeam is committed to improving patient outcomes through advanced technology solutions.

The company is at the forefront of transforming healthcare interactions, thus positioning itself as a critical player in the evolving landscape of healthcare technology. Its innovative solutions not only streamline processes but also ensure that care teams have access to vital patient information, facilitating improved communication and coordination.

Industry Overview

The healthcare technology industry in the United States has witnessed significant growth, especially in the wake of the COVID-19 pandemic. The demand for high-quality healthcare services has surged, leading to a

View Source

Similar Deals

Broadview Ventures and Advent Life Sciences Relief Cardiovascular

2025

Series A Medical Devices & Implants United States of America
SPRIM Global Investments and William Taylor Nominees RheumaGen, Inc.

2025

Series A Bio Therapeutic Drugs United States of America
Plural Teton.ai

2025

Series A Residential & Long-Term Care United States of America
Five Elms Capital Motivity

2025

Series A Healthcare Facilities & Services (NEC) United States of America
Ballast Point Ventures Medsender

2025

Series A Healthcare Facilities & Services (NEC) United States of America
AIX Ventures Ataraxis AI

2025

Series A Bio Diagnostics & Testing United States of America

Wittington Ventures

invested in

WellBeam

in 2025

in a Series A deal

Disclosed details

Transaction Size: $10M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert